Molecular cloning,purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein

The Brucella mdh gene was successfully cloned and expressed in E. coli. The purified recombinant malate dehydrogenase protein (rMDH) was reactive to Brucella-positive bovine serum in the early stage, but not reactive in the middle or late stage, and was reactive to Brucella-positive mouse serum in the late stage, but not in the early or middle stage of infection. In addition, rMDH did not react with Brucella-negative bovine or mouse sera. These results suggest that rMDH has the potential for use as a specific antigen in serological diagnosis for early detection of bovine brucellosis.     

Theileria orientalis: a review

Theileria orientalis (also known historically as T. sergenti and T. buffeli) is responsible for benign or non-transforming theileriosis, and exerts its major effect through erythrocyte destruction. The life cycle of T. orientalis is essentially similar to that of other Theileria species, except that the schizonts do not induce transformation and fatal lymphoproliferation. The pathogenesis of anaemia as a result of infection is not clearly established and may be multifaceted. Clinical signs of weakness, reluctance to walk and abortion are early but non-specific indications of disease, particularly if accompanied by a history of cattle being moved. Physical examination may reveal pallor (pale eyes, vaginal mucosa), pyrexia, and elevated heart and respiratory rates. T. orientalis is an economically important parasite of cattle in New Zealand, Australia and Japan, especially where naïve animals are introduced into an endemic area or in animals under stress. Increased awareness of the risks posed by the parasite is required to enable management practices to be implemented to minimise its impact.     

Interactions of local habitat type,landscape composition and flower availability moderate wild bee communities

Context

Landscape and local habitat traits moderate wild bee communities. However, whether landscape effects differ between local habitat types is largely unknown.

Objectives

We explored the way that wild bee communities in three distinct habitats are shaped by landscape composition and the availability of flowering plants by evaluating divergences in response patterns between habitats.

Methods

In a large-scale monitoring project across 20 research areas, wild bee data were collected on three habitats: near-natural grassland, established flower plantings and residual habitats (e.g. field margins). Additionally, landscape composition was mapped around the research areas.

Results

Our monitoring produced a dataset of 27,650 bees belonging to 324 species. Bee communities on all three habitats reacted similarly to local flower availability. Intensively managed grassland in the surrounding landscape had an overall negative effect on the studied habitats. Other landscape variables produced diverging response patterns that were particularly pronounced during early and late season. Bee communities in near-natural grassland showed a strong positive response to ruderal areas. Flower plantings and residual habitats such as field margins showed a pronounced positive response to extensively managed grassland and woodland edges. Response patterns regarding bee abundance were consistent with those found for species richness.

Conclusion

We advise the consideration of local habitat type and seasonality when assessing the effect of landscape context on bee communities. A reduction in the intensity of grassland management enhances bee diversity in a broad range of habitats. Moreover, wild bee communities are promoted by habitat types such as ruderal areas or woodland edges.

     

Clinical efficacy of diclofenac sodium and flunixin meglumine as adjuncts to antibacterial treatment of respiratory disease of calves

Objective To compare the efficacy of the non-steroidal antiinflammatory drugs, diclofenac sodium and flunixin meglumine as adjuncts to the antibiotic treatment of bovine respiratory disease (BRD). Procedure We randomly allocated 80 Holstein calves with BRD to three groups. All the calves received a dose of 2.5 mg/kg tulathromycin by single subcutaneous injection and two of the groups received, in addition, either 2.5 mg/kg diclofenac sodium as a single intramuscular injection (diclofenac group, n = 30) or 2.2 mg/kg flunixin meglumine as an intravenous injection on the first three consecutive days after tulathromycin administration (flunixin group, n = 30). All calves were given a clinical score prior to initial treatment (day 0) and after treatment (days 1, 2, 3, 7 and 14) by observing appetite, demeanour, rectal temperature, the rate and type of respiration, presence or absence of coughing, and nasal discharge. Results During the first 48 h, improvement of adverse signs of respiratory disease, such as pyrexia and elevated respiratory rate, and of a high clinical index score was significant in the two adjunct groups compared with the calves receiving antibiotic alone. The reduction in pyrexia was greatest in the diclofenac group. There were no statically significant differences between treatment groups with regard to eventual perceived recovery from respiratory disease in 14 days. Conclusion In this trial, a single intramuscular dose of diclofenac sodium was equally effective as three intravenous injections of flunixin meglumine given on consecutive days as adjunctive therapy for BRD.